Subspecies: clade-626 (HMT-0626) Primary Body Site: Oral
Download Options
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - manuscript in revision)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.06 | 0.07 | 0.01 | 1.67 | 2.20 | 3.63 | 0.17 | 0.05 | 0.26 | 0.02 | 0.03 | 0.01 | 0.04 | 1.00 | 0 | 0.02 | 0 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0 | 0 | 0 | 0 | 0 | 3.63 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 1.00 | 0 | 0 | 0 | 0 |
| 90thp | 0.13 | 0.08 | 0.01 | 3.10 | 6.12 | 3.63 | 0.36 | 0.10 | 0.55 | 0.03 | 0.08 | 0.03 | 0.01 | 1.00 | 0 | 0.04 | 0.01 | 0 |
| Stdev | 0.09 | 0.47 | 0.01 | 1.55 | 2.80 | 0 | 0.17 | 0.06 | 0.41 | 0.15 | 0.03 | 0.02 | 0.19 | 0 | 0 | 0.05 | 0.01 | 0.01 |
| Prev(%) | 79.17 | 45.06 | 66.67 | 80.00 | 68.73 | 100.00 | 62.50 | 57.14 | 90.91 | 34.52 | 92.31 | 100.00 | 80.00 | 100.00 | 75.00 | 62.50 | 75.53 | 65.33 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.56 | 0.39 | 5.77 | 7.80 | 3.73 | 0.47 | 1.71 | 1.79 | 0.16 | 0 |
| n | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 |
| 10thp | 0 | 0 | 0.56 | 1.06 | 0.57 | 0 | 0.07 | 0.05 | 0 | 0 |
| 90thp | 0.92 | 0.74 | 11.55 | 16.36 | 9.70 | 0.99 | 6.00 | 5.56 | 0.42 | 0 |
| Stdev | 1.77 | 1.03 | 4.94 | 6.34 | 4.61 | 0.60 | 2.59 | 3.01 | 0.24 | 0.01 |
| Prev(%) | 74.03 | 79.22 | 100.00 | 100.00 | 98.70 | 85.71 | 96.10 | 93.51 | 79.22 | 7.79 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to G. haemolysans, G. morbillorum, and G. sanguinis were assigned one-third to each taxon.
Reads equally close to G. haemolysans, G. morbillorum, and G. sanguinis were assigned one-third to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.15 | 0.15 | 0.88 | 1.76 | 0.83 | 0.20 | 0.60 | 0.52 | 0.24 | 0 |
| n | 148 | 148 | 148 | 148 | 148 | 148 | 148 | 148 | 148 | 143 |
| 10thp | 0.01 | 0.01 | 0.10 | 0.23 | 0.17 | 0.04 | 0.05 | 0.05 | 0.02 | 0 |
| 90thp | 0.27 | 0.26 | 1.91 | 4.05 | 1.62 | 0.40 | 1.54 | 1.07 | 0.50 | 0 |
| Stdev | 0.27 | 0.31 | 0.89 | 1.78 | 0.91 | 0.16 | 0.68 | 0.67 | 0.24 | 0 |
| Prev(%) | 90.54 | 90.54 | 99.32 | 99.32 | 99.32 | 96.62 | 97.30 | 97.97 | 97.30 | 1.40 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.49 | 0.33 | 5.29 | 7.96 | 3.94 | 0.47 | 1.26 | 1.05 | 0.08 | 0.11 | 0.06 | 0.03 | 0.34 | 0.26 | 0 | 0 | 0 | 0 |
| n | 151 | 151 | 143 | 146 | 149 | 130 | 336 | 150 | 155 | 300 | 348 | 353 | 174 | 217 | 71 | 74 | 76 | 153 |
| 10thp | 0 | 0 | 0.59 | 1.55 | 0.40 | 0 | 0.01 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.08 | 0.78 | 10.35 | 15.55 | 9.44 | 1.22 | 3.28 | 2.55 | 0.16 | 0.28 | 0.14 | 0.05 | 1.12 | 0.70 | 0 | 0 | 0 | 0 |
| Stdev | 1.44 | 0.81 | 4.44 | 6.97 | 4.69 | 0.66 | 2.58 | 2.12 | 0.17 | 0.27 | 0.25 | 0.14 | 0.70 | 0.61 | 0 | 0 | 0 | 0 |
| Prev(%) | 88.08 | 84.77 | 100.00 | 97.94 | 97.99 | 82.31 | 90.18 | 92.67 | 76.13 | 50.67 | 35.92 | 29.46 | 46.55 | 42.86 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.25 | 0.17 | 4.34 | 7.45 | 0 | 0 | 0 | 0 | 0 | 0.14 | 0 | 0.22 | 0.51 | 0.63 | 0 | 0.02 | 0.01 | 0.01 |
| n | 405 | 410 | 405 | 403 | 391 | 336 | 321 | 411 | 411 | 261 | 314 | 324 | 145 | 150 | 174 | 183 | 191 | 411 |
| 10thp | 0.01 | 0 | 0.53 | 1.21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.41 | 0.38 | 9.77 | 18.06 | 0 | 0 | 0 | 0 | 0 | 0.35 | 0 | 0.40 | 1.10 | 1.33 | 0 | 0.01 | 0.01 | 0 |
| Stdev | 1.42 | 0.40 | 5.05 | 6.93 | 0 | 0 | 0 | 0 | 0 | 0.40 | 0 | 0.86 | 1.63 | 1.91 | 0 | 0.10 | 0.16 | 0.05 |
| Prev(%) | 94.07 | 90.00 | 99.26 | 100.00 | 0 | 0 | 97.51 | 0 | 0 | 60.54 | 0 | 52.47 | 74.48 | 72.00 | 0 | 19.67 | 18.85 | 7.30 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.15 | 0.07 | 2.26 | 2.96 | 1.14 | 0.27 | 0.66 | 0.99 | 0.15 | 0.02 |
| n | 74 | 34 | 43 | 35 | 28 | 50 | 33 | 31 | 40 | 20 |
| 10thp | 0 | 0 | 0.06 | 0.11 | 0.05 | 0.02 | 0.02 | 0.02 | 0.01 | 0 |
| 90thp | 0.51 | 0.10 | 8.47 | 8.26 | 3.31 | 0.44 | 1.67 | 2.90 | 0.47 | 0.04 |
| Stdev | 0.36 | 0.18 | 3.39 | 6.20 | 1.46 | 0.65 | 1.32 | 2.17 | 0.26 | 0.07 |
| Prev(%) | 79.73 | 88.23 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 95.00 | 25.00 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - manuscript in revision)
No Notes

